Brian Slomovitz and David M. Gershenson/LinkedIn
May 14, 2026, 17:13
Ribociclib Plus Letrozole in Recurrent Low-Grade Serous Carcinoma of the Ovary – IJGC
International Journal of Gynecological Cancer (IJGC), shared a post on LinkedIn:
”New IJGC Conversations episode!
Ribociclib+Letrozole in Recurrent Low-Grade Serous Carcinoma of the Ovary: GOG3026 with Brian Slomovitz and David Gershenson
Tune in now.”
Proceed to the video attached to the post.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Sep 18, 2026, 20:27Hrishikesh Pai: Rethinking Male Infertility
-
Sep 18, 2026, 20:25Eric Verdin: Wrapping Up the Reproductive Aging Summit at the Center for Healthy Aging in Women
-
Sep 18, 2026, 20:21Investigating Pregnancy Outcomes in Women with Idiopathic POI – RBMO
-
Sep 18, 2026, 20:18Sue Ritchie: Why Aren’t We Talking About Male Fertility More?
-
Sep 18, 2026, 20:13Salma Yasin: Every Day of BFS Study Week 2026 Has Been an Exceptional Learning Experience
-
Sep 18, 2026, 20:01Qingcai Wang: Over 35 and Torn Between Trying Longer and Starting IVF?
-
Sep 18, 2026, 19:58Bhumika: Can a Woman Become Pregnant Again While Already Pregnant?
-
Sep 18, 2026, 19:5215 More Experts Join the International Fertility Forum Mumbai 2026
-
Sep 18, 2026, 19:50Curious About What Happens Behind the Scenes in the Labs? – Sims IVF